Lidocaína + Adrenalina Normogen

Lidocaine hydrochloride, the active ingredient in Lidocaína + Adrenalina Normogen, is a local anesthetic with vasoconstrictor presented as an injectable solution for infiltration and perineural use. It provides local anesthesia for surgical procedures and dental work in adult patients.

GNH USA supplies Lidocaína + Adrenalina Normogen as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, transplant centres, oncology centres, pharmacies and clinics worldwide.

Lidocaine combined with epinephrine is used for local anesthesia in procedures requiring nerve block or tissue infiltration.

- Local infiltration anesthesia: provides rapid onset numbness for minor surgical or dental procedures. - Perineural (nerve block) anesthesia: prolongs analgesia during regional nerve block techniques. - Minor dermatologic procedures: facilitates painless excision or biopsy of skin lesions.

Adverse reactions may occur after administration of lidocaine/epinephrine.

Common Side Effects: - Transient burning or stinging at the injection site - Mild dizziness or light‑headedness - Nausea or mild gastrointestinal upset - Tachycardia or palpitations

Serious or Rare Side Effects: - Severe allergic reaction (anaphylaxis) - Cardiac arrhythmias, including ventricular tachycardia - Seizures, especially with high plasma lidocaine levels - Methemoglobinemia, a rare blood disorder

When using lidocaine with epinephrine, consider the following safety measures.

- Allergy assessment: verify no known hypersensitivity to lidocaine or epinephrine. - Cardiovascular status: use cautiously in patients with uncontrolled hypertension or arrhythmias. - Pregnancy: limited data; weigh potential benefits against risks. - Pediatric use: dose adjustment required; monitor closely. - Drug interactions: avoid concurrent MAO inhibitors that may potentiate epinephrine effects. - Store at ambient temperature: keep in original container, protect from light and moisture.

Lidocaine/epinephrine may interact with several drug classes.

Major Interactions (Avoid): - MAO inhibitors: may cause hypertensive crisis with epinephrine. - Class I antiarrhythmics (e.g., quinidine): increase lidocaine toxicity. - Beta‑blockers: may potentiate epinephrine‑induced hypertension.

Moderate Interactions (Monitor Closely): - Tricyclic antidepressants: may raise lidocaine plasma concentrations. - CYP3A4 inhibitors (e.g., erythromycin): may reduce lidocaine clearance. - Non‑steroidal anti‑inflammatory drugs: may increase bleeding risk due to vasoconstriction.